Adult vaccines

Pursuant to the preliminary order issued on March 16, 2026, in American Academy of Pediatrics et al. v. Kennedy et al. ... the July 2, 2025 immunization schedule (as amended on April 27, 2026 to add the ACIP's April 2025 RSV recommendation as adopted by HHS) posted here is the current CDC Adult Immunization Schedule by Age for Healthcare Professionals.

Our note: The ellipsis omits the order's own description of what it stayed: the case number, and the clause "which stayed all votes taken by the ACIP during its June, September and December 2025 meetings, and further stayed the Acting CDC Director's January 5, 2026 Decision Memo revising the CDC's childhood immunization schedule". DATE: the page's own stamp is July 2, 2025, which is the schedule in force; the April 27, 2026 amendment is named inside the quote rather than used as the row date, because the page dates itself to July 2, 2025.

CDC recommends vaccination every 10 years for all adults to maintain protection against tetanus. Once an adult has received a dose of Tdap, administer Td or Tdap for their booster doses.

Our note: No ages are attached to this recommendation on the page, which says "all adults", so both age fields are empty. The adult schedule adds two rows this sentence does not cover: one dose of Tdap in each pregnancy, and one dose of Td or Tdap for wound management.

CDC recommends 2 doses of recombinant zoster vaccine (RZV) to prevent shingles and related complications in adults aged ≥50 years.

Our note: The same page adds a second population the age row does not cover: 2 doses of RZV for adults aged 19 years and older who are or will be immunodeficient or immunosuppressed because of disease or therapy. It also states that a prior episode of shingles, a prior dose of the discontinued Zostavax, and the absence of a documented chickenpox history all make no difference to the recommendation.

CDC recommends pneumococcal vaccination for children younger than 5 years and adults 50 years or older.

Our note: The quoted sentence covers children as well as adults; only the adult clause is used here, and the population cell says so. The adult instruction on the same page reads: "Administer PCV15, PCV20, or PCV21 for all adults 50 years or older" who have never received a conjugate vaccine or whose history is unknown. If PCV15 is used, a dose of PPSV23 follows one year later; if PCV20 or PCV21 is used, no PPSV23 dose is indicated. Adults under 50 with risk conditions are covered by a separate risk-based row.

The Advisory Committee on Immunization Practices (ACIP) recommends hepatitis B (HepB) vaccination among all infants at birth, unvaccinated children younger than 19 years of age, adults aged 19–59 years, and adults aged 60 years and older with risk factors for hepatitis B or without identified risk factors but seeking protection.

Our note: No stop age is set because the recommendation does not close at 59: adults 60 and older are covered both with risk factors and, on request, without them. The number of doses comes from the adult schedule's own hepatitis B row, which reads "2, 3, or 4 doses depending on vaccine or condition".

Vaccination is not recommended for everyone older than age 26 years. Some adults ages 27 through 45 years might decide to get the HPV vaccine based on discussion with their clinician, if they did not get adequately vaccinated when they were younger.

Our note: Routine HPV vaccination runs through age 26 and can be started at 9; this row covers the band above it, which is the one that concerns most readers of this page. The page states its reason for the weaker position: "HPV vaccination of people in this age range provides less benefit, for several reasons, including that more people in this age range have already been exposed to HPV."

Part of that ongoing work is to maintain our childhood and adult vaccine schedules, which have just been updated for 2026.

Our note: From the AAFP Chief Medical Officer's post announcing the 2026 schedules. DATE: the page's own publish-date element reads March 24, 2026, which is used; a second dateline, April 24, 2026, is bolded lower on the page, and the earlier of the two is taken. NO AGES AND NO INTERVAL are entered because the quoted sentence states none; AAFP's adult schedule covers ages 19 and older but that is stated on a different, undated page. That page also says: "This version of the adult immunization schedule has been adopted by the American Academy of Family Physicians (AAFP)."

Although the American Academy of Family Physicians (AAFP) has usually endorsed the immunization schedule published by the Centers for Disease Control and Prevention (CDC), which is typically based on the recommendation of the Advisory Committee of Immunization Practices (ACIP), the AAFP published its own 2025 recommendations with a few substantive differences.

Our note: From American Family Physician 2026;113(1):98-99, the page stating "This article was updated on January 15, 2026", the date used. No ages and no interval are stated for this position, so those cells are empty. On the ADULT schedule specifically, AAFP's own adult schedule page says: "The CDC's 2025 immunization schedules, which are not endorsed by the AAFP, can be found here." That page carries no publication date, which is why it is quoted here rather than used as a dated row of its own.

Routine pneumococcal vaccination is now recommended at 50 years of age rather than the previous recommendation of 65 years.

Our note: Listed under Key Points for Practice. This is a row where AAFP and CDC agree, and it is the change most likely to affect a reader in their fifties: the threshold moved down from 65. The quoted sentence gives no dose schedule, so the interval cell is empty; the doses are on the CDC pneumococcal row above. Same source and date convention as the row above.